News

We are very happy to welcome Mikael Haglund as Pharmetheus’ Human Resources Manager. Mikael has been working with HR for close to 15 years, across different industries, such as housing, media &

It is time to celebrate the opportunity, that the PAGE conference (www.page-meeting.org) brings, to share science within the MIDD community. We are a group of ~15 from the Pharmetheus team, excited to

Pharmetheus is offering virtual professional consulting sessions (~30 min), free of charge, until the 16th of Sep in connection to the PAGE 2021 meeting.Note that these sessions are open to everyone and

Treatments improving: diary-based symptom score, diary-based rescue medication use, and/or FEV1 should also produce a better outcome in exacerbations in asthma patients; this is what the study conducted by Robin Svensson, Jakob

Exposure-safety analyses are often a great complement to exposure-response analyses in order to drive key MIDD decisions such as therapeutic dose selection. In this example, our colleague Celine Sarr and collaborators from

We are happy to have Linda Hafdell onboard as a contract manager. Linda’s previous work experience mainly consists of public procurement within the fields of IT, scientific instruments and other services. She

We are happy to welcome Eric Salgado to our growing PBPK team as an Associate Consultant. Eric’s research experience includes PBPK/TMDD modeling of monoclonal antibodies in tumors and tumor-draining lymph nodes as

We are currently refining and developing our internal training course curriculum for the remainder of 2021 into 2022. We can also reflect upon the courses delivered during the first half of 2021.

We are thrilled to have Anna on board as an Associate Consultant. Her experience includes PK modeling and simulations for dosing individualization of antibodies and small molecules, and her publications include a